期刊文献+

雾化吸入α_1-抗胰蛋白酶对绿脓杆菌肺部感染大鼠的作用研究 被引量:1

Effect of aerosolized α_1-antitrypsin on Pseudomonas aeruginosa pneumonia in rats
下载PDF
导出
摘要 目的 :观察雾化吸入 α1 抗胰蛋白酶 (α1 AT)对绿脓杆菌肺部感染大鼠体内炎症反应的抑制作用及其机制。方法 :雾化吸入 α1 AT来干预绿脓杆菌肺部感染大鼠 ,比较干预组与对照组动物的死亡率、肺泡灌洗液 (BAL F)中细胞总数、蛋白酶 (NE)活性、白介素 8(IL 8)含量及肺内细菌总数。结果 :接种绿脓杆菌3.0× 10 6 CFU的大鼠 ,干预组动物死亡率 (8% )明显低于对照组 (5 8% ,P<0 .0 5 )。接种绿脓杆菌 2 .4× 10 6 CFU的大鼠 ,干预组 BAL F中 NE活性、IL 8含量及肺内细菌总数均较对照组显著降低 (P均 <0 .0 5 )。结论 :雾化吸入 α1 AT可抑制绿脓杆菌肺部感染大鼠肺内炎症反应程度 ,降低急性期动物死亡率及增强机体对细菌的清除力。 Objective:To know if aerosolized α 1antitrypsin(α 1AT) can suppress inflammatory response and its mechanism in rats with Pseudomonas aeruginosa(PA) pneumonia.Methods:Fortyeight SD rats were involved and were divided into two groups randomly.One group was inoculated 3 0×10 6 CFU PA,the other group was 2 4×10 6 CFU.Animals were aerosolized 10 ml liquid every day,with was NS or α 1AT.Then the mortality rate,the total cell counts,the activity of NE,the capacity of IL8 in bronchoalveolar lavage fluid(BALF) and the bacterial clone forming units of lungs were compared.Results:In animals with 3 0×10 6 CFU PA inoculation,the mortality rate of the aerosolized group was 8%,which was lower than the control group(58%, P <0 05).In animals with 2 4×10 6 CFU PA inoculation,the activity of NE,the capacity of IL8 in BALF and the bacterial clone forming units of lungs in aerosolized α 1AT group were lower than those in the controls(all P <0 05).Conclusions:Aerosolized α 2AT can inhibit the inflammatory response in rats with PA pneumonia,reduce the mortality rate in acute phase,and improve the host clearance capacity to bacteria.
出处 《中国危重病急救医学》 CAS CSCD 2002年第5期282-284,共3页 Chinese Critical Care Medicine
基金 卫生部科技基金资助项目 (No.98115 0 )
关键词 雾化吸入 Α1-抗胰蛋白酶 绿脓杆菌 肺部感染 大鼠 作用 antitrypsin Pseudomonas aeruginosia pulmonary infection rat
  • 相关文献

参考文献1

二级参考文献3

共引文献7

同被引文献28

  • 1Duk SH, Evelyn N, Mark L, et al. Process for separating alpha-1-proteinase inhibitor from COHN Ⅳ. sub. 1 + Ⅳ. sub. 4 paste[M]. USP5616693, April 1 1997.
  • 2Kee SM. , Cook PI. , Smith JR. , et al. Method for purification of alpha-1-antitrypsin[ M]. USP20040124143, July 1,2004.
  • 3Vemuri S, Yu CD, Roosdorp N. Effect of cryoprotectants on freezing, lyophilization, and storage of lyophilized recombinant alpha 1-antitrypsin formulations [ J ]. J Pharm Sci Technol, 1994, 48(5) : 241-246.
  • 4Knag HA, Sohn jh, Choi es, et al. Glycosylation of human alpha 1-antitrypsin in Saccharomyces cerevisiae and methylotrophic yeasts[J]. Yeast, 1998, 14(4): 371-381.
  • 5Flootte TR, Brantly ML, Spencer LT, et al. Phase Ⅰ trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT- deficient adults[ J]. Hum Gene Ther, 2004, 15( 1 ) : 93-128.
  • 6Wewers MD, Casolaro MA, Seller SE, et al. Replacement Therapy for Alpha 1-antitrypsin Deficiency Association with Emphysema[J]. N Engl J Med, 1987, 316: 1 055-1 062.
  • 7Barker AF, Semsen F, Pasley D, et al. Replacement therapy for hereditary alpha 1-antitrypsin deficiency. A program for long-term administration [J]. Chest, 1994, 105: 1 406.
  • 8Churg A, Changshi X, Joanne LW, et al. alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse [J]. Am J Respir Crit Care Med, 2003, 168(2) :199-207.
  • 9Lee CT, et al. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome [ J ]. N Engl J Med, 1981, 304: 192-196.
  • 10Birrer P, McElvaney NG, Rudeberg A, et al. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis[J]. Am J Respir Crit Care Med, 1994, 150(1) : 207-213.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部